QQQ surges 15% in April, on pace for strongest month since 2002

Seeking Alpha - Thu, 04/30/2026 - 13:10

This Simple 2-ETF Mix May Spell The End Of 60/40 Portfolio Mania

Seeking Alpha - Thu, 04/30/2026 - 13:08

KKR bags over $10B financing for AI infrastructure developer launch - report

Seeking Alpha - Thu, 04/30/2026 - 13:04

Meta Q1 Review: Investors Hate Capex When They Should Love It

Seeking Alpha - Thu, 04/30/2026 - 13:04

Mechanics Bancorp 2026 Q1 - Results - Earnings Call Presentation

Seeking Alpha - Thu, 04/30/2026 - 13:03

Blue Owl Capital Inc. 2026 Q1 - Results - Earnings Call Presentation

Seeking Alpha - Thu, 04/30/2026 - 13:02

Invitation Homes outlines new $500M repurchase authorization as forward pipeline stands just over $200M

Seeking Alpha - Thu, 04/30/2026 - 13:02

Tenet outlines $1.6B-$1.83B 2026 adjusted free cash flow after NCI while reaffirming full-year guidance

Seeking Alpha - Thu, 04/30/2026 - 13:02

Trinity projects $2.20 to $2.40 full-year EPS amid expected $160M to $180M gains

Seeking Alpha - Thu, 04/30/2026 - 13:02

InterDigital expects Q2 revenue of $139M-$143M while maintaining full-year guidance

Seeking Alpha - Thu, 04/30/2026 - 13:02

ILPT anticipates $1.27 to $1.34 normalized FFO per share in 2026 as it prices $1.6B JV refinancing at 5.71%

Seeking Alpha - Thu, 04/30/2026 - 13:02

The Hanover Insurance Group, Inc. 2026 Q1 - Results - Earnings Call Presentation

Seeking Alpha - Thu, 04/30/2026 - 13:01

The Southern Company 2026 Q1 - Results - Earnings Call Presentation

Seeking Alpha - Thu, 04/30/2026 - 13:01

Alector halts mid-stage trial for Alzheimer’s candidate developed with GSK

Seeking Alpha - Thu, 04/30/2026 - 13:01

X-FAB Silicon Foundries SE 2026 Q1 - Results - Earnings Call Presentation

Seeking Alpha - Thu, 04/30/2026 - 13:01

AI investing cycle reaching inflection point - Wells Fargo's Kwon

Seeking Alpha - Thu, 04/30/2026 - 12:59

L3Harris reaffirms $23B-$23.5B 2026 revenue and raises GAAP EPS to $11.40-$11.60 as it files S-1 for AXYV IPO

Seeking Alpha - Thu, 04/30/2026 - 12:56

Kymera expects KT-579 Phase I data in 2H 2026 while targeting KT-621 BROADEN2 enrollment completion by year-end

Seeking Alpha - Thu, 04/30/2026 - 12:55

Cullinan Therapeutics: Cash-Rich With A Major 2027 FDA Catalyst

Seeking Alpha - Thu, 04/30/2026 - 12:53

e.l.f.'s rhode expands to Sephora Europe

Seeking Alpha - Thu, 04/30/2026 - 12:53

Pages